Targeted therapy of underlying conditions in patients with persistent atrial fibrillation and mild to moderate stable heart failure: long term outcome of the RACE 3 Trial

23 April 2021 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Late Breaking Clinical Trials Treatment EHRA Premium Access EHRA 2021

ESC 365 is supported by

ESC 365 is supported by